The legal battle between OpenAI and DeepSeek has ignited heated debate about artificial intelligence innovation, intellectual property rights, and competitive dynamics in the AI industry. OpenAI–the undisputed industry leader in generative AI backed by billions in funding–alleges that DeepSeek violated its terms of service by leveraging a technique known as “distillation” to build a competitive […]

In recent years, corporate boardroom diversity efforts have gained momentum. This shift is fueled by growing recognition of the benefits that diverse perspectives bring to decision-making and corporate performance. However, there have been significant setbacks for the diversity of corporate boards in the US in recent months, strengthened by President Trump’s Executive Order terminating government […]

Under Rule 14a-8 of the Securities Exchange Act of 1934, shareholders are entitled to submit proposals for company action for inclusion in a company’s proxy statement to be voted on at annual shareholder meetings. In theory, shareholder proposals empower investors to shape corporate action by putting plans shareholders wish to see the company implement to […]

What do trailer parks, hospitals, prison services, and accounting firms have in common? Private equity (PE) has acquired a stake in all of them—and it’s not stopping there. From 2023 to 2024, PE firms closed $565 billion in announced deals, a 25% increase in value. With so much capital in play, PE is ever on […]

Artificial intelligence (“AI”) is transforming every aspect of our lives, and the biotechnology field is no exception. It drives significant advancements across various areas, such as drug discovery and development, genetic research, personalized medicine, and medical diagnostics. These innovations rely on vast amounts of large complex datasets, often called big data, both as input for […]